Tag: cyberattack

AMGEN PRESENTS NEW DATA ACROSS ITS CARDIOMETABOLIC PORTFOLIO AT AMERICAN DIABETES ASSOCIATION 86TH SCIENTIFIC SESSIONS

VESALIUS-CV Subgroup Results Show Repatha® Reduces Risk of First Major Cardiovascular Events by 29% in People Living with High-Risk DiabetesNew Real-World Data Highlight Treatment...

EULAR 2026: Dapirolizumab Pegol Shows Potential to Reduce Flare Rates and Maintain Disease Control in Systemic Lupus Erythematosus

BRUSSELS, Belgium and CAMBRIDGE, Mass., June 04, 2026 (GLOBE NEWSWIRE) -- UCB (Euronext Brussels: UCB) and Biogen Inc. (Nasdaq: BIIB) today announced data, comprising two posters and three abstracts, at the European Alliance of Associations for Rheumatology (EULAR) 2026 Congress, demonstrating the clinical profile of dapirolizumab pegol (DZP), an investigational biologic in patients with systemic lupus erythematosus (SLE).

AMGEN ANNOUNCES 2025 THIRD QUARTER DIVIDEND

THOUSAND OAKS, Calif., Aug. 1, 2025 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that its Board of Directors declared a $2.38 per share dividend for...

Clorox Reports Q4 and FY25 Results, Provides FY26 Outlook

Delivers strong margin expansion and adjusted EPS growth for FY25 despite challenging environment in the second half of the fiscal year OAKLAND, Calif., July...

First Citizens BancShares Reports Second Quarter 2025 Earnings, Announces Additional Share Repurchase Plan

RALEIGH, N.C., July 25, 2025 /PRNewswire/ -- First Citizens BancShares, Inc. ("BancShares") (Nasdaq: FCNCA) reported earnings for the second quarter of 2025. ...

UCB announces positive results from GEMZ Phase 3 study of fenfluramine in CDKL5 deficiency disorder

Phase 3 study met primary and most key secondary clinical endpointsThis marks the third developmental and epileptic encephalopathies (DEE) population for fenfluramine with positive phase...

Commvault Named a Leader for 14th Consecutive Time in the 2025 Gartner® Magic Quadrant™ for Backup and Data Protection Platforms

Recognized by Gartner as a Leader for Completeness of Vision and Ability to Execute TINTON FALLS, N.J., June 26, 2025 /PRNewswire/ -- Commvault, a...

Barrack, Rodos & Bacine Investigating Cyberattack and Potential Data Breach at Erie Insurance

PHILADELPHIA, June 24, 2025 (GLOBE NEWSWIRE) -- Barrack, Rodos & Bacine is actively investigating a reported cyberattack on Erie Indemnity Corporation, which operates under the name Erie Insurance.

- A word from our sponsors -

Newsletter Signup

Name(Required)

First Last

Email(Required)

Enter Email Confirm Email

CAPTCHA

Privacy(Required)

I agree with the storage and handling of my data by this website. - Privacy Policy *

Comments

This field is for validation purposes and should be left unchanged.

HomeTagsCyberattack

RMG ML Sports Holdings Announces the Pricing of $200 Million Initial Public Offering

Ramaco Resources to Participate in StoneX Fourth Annual Natural Resources Summit

MNA: Brigham Nurses to Hold Strike Authorization Vote as Mass General Brigham Contract Proposals Undermine Safe Patient Care and the BWH Nursing Workforce

Tag: cyberattack

AMGEN PRESENTS NEW DATA ACROSS ITS CARDIOMETABOLIC PORTFOLIO AT AMERICAN DIABETES ASSOCIATION 86TH SCIENTIFIC SESSIONS

EULAR 2026: Dapirolizumab Pegol Shows Potential to Reduce Flare Rates and Maintain Disease Control in Systemic Lupus Erythematosus

AMGEN ANNOUNCES 2025 THIRD QUARTER DIVIDEND

Clorox Reports Q4 and FY25 Results, Provides FY26 Outlook

First Citizens BancShares Reports Second Quarter 2025 Earnings, Announces Additional Share Repurchase Plan

UCB announces positive results from GEMZ Phase 3 study of fenfluramine in CDKL5 deficiency disorder

Commvault Named a Leader for 14th Consecutive Time in the 2025 Gartner® Magic Quadrant™ for Backup and Data Protection Platforms

Barrack, Rodos & Bacine Investigating Cyberattack and Potential Data Breach at Erie Insurance

Newsletter Signup

Explore

Press Releases

News & Opinion

Living

Others

Follow us